Anebulo Pharmaceuticals, Inc. (ANEB) stock

ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026Score 0/30

$0.00+0.00 (+75.00%)

Close on Oct 19, 2026Market cap $28.76KP/E –Yield –

Anebulo Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Anebulo Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?